Webcast is supported by an unrestricted educational grant from:

SCIENTIFIC AGENDA
Session VII: Treatment update part II
Moderator: Bart Barlogie, MD, PhD

Immunosurveillance and immunotherapy: Ready for prime time?
Roundtable discussion
Discussion Leader: Madhav V. Dhodapkar, MD
Participants: Madhav V. Dhodapkar, MD, Nikhil Munshi, MD, Frits Van Rhee, MD, PhD and Qing Yi, MD, PhD

Bortezomib combinations for relapsed/refractory patients
Nikhil Munshi, MD

Bortezomib-based combinations as frontline therapy
Donna M. Weber, MD

Front-line therapy of myeloma: Role of CC-5013 and thalidomide
S. Vincent Rajkumar, MD

Arsenic trioxide, liposomal doxorubicin
Mohamad Hussein, MD

Combination therapies: The total therapy approach
Bart Barlogie, MD, PhD